Real-World Treatment Patterns and Patient reported outcome in COPD (REMIND) - REMIND
Study identifier:D5980R00080
ClinicalTrials.gov identifier:NCT05903989
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A secondary database study using COPD cohort study in Japan to investigate health status of COPD patients with different inhaler treatment
Medical condition
COPD
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
708
Study type
Observational
Age
n/a - n/a
Date
Study Start Date: 11 Sept 2023
Primary Completion Date: 24 Oct 2023
Study Completion Date: 24 Oct 2023
Study design
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 May 2024 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| LAMA | - |
| LAMA plus LABA | - |
| ICS plus LABA | - |
